SCHEMBL7573687

SCHEMBL7573687

O=C(O)C(Nc1ccc(O)cc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
FPR2 P25090 1/20 0.47
NPY5R Q15761 1/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA12 O43570 1/20 0.43
MMP2 P08253 1/20 0.43
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
CYP2D6 P10635 1/20 0.42
SRC P12931 1/20 0.42
KMT2A Q03164 2/20 0.42
ATM Q13315 1/20 0.42
GAA P10253 1/20 0.42
GFER P55789 1/20 0.42
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
MAPT P10636 1/20 0.41
DEGS1 O15121 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2483521 0.88 FPR2 (0.49) FPR2CA1CA2CA12CYP2D6
SCHEMBL146704 0.88 FPR2 (0.49) FPR2CA1CA2CA12CYP2D6
SCHEMBL2483519 0.88 FPR2 (0.49) FPR2CA1CA2CA12CYP2D6
SCHEMBL28534876 0.86 FPR2 (0.47) FPR2CA1CA2CA12CYP2D6
SCHEMBL11301777 0.84 CA12 (0.45) FPR2CA12CYP2D6SRCKMT2A
SCHEMBL7575514 0.84 FPR2 (0.46) FPR2CA1CA2CYP2D6SRC
SCHEMBL2482091 0.84 SMN1; SMN2 (0.53) FPR2CA1CA12KMT2AGAA
SCHEMBL2483340 0.84 NPC1 (0.47) FPR2CA12MMP2CYP2D6KMT2A
SCHEMBL1696032 0.84 NPC1 (0.47) FPR2CA12MMP2CYP2D6KMT2A
SCHEMBL7583413 0.84 FPR2 (0.67) MAOAMAOBFPR2CA12MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2002-09-25 EP disclosed
WO-2001003684-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2001-01-18 WO disclosed